tiprankstipranks
Qlucore AB (SE:QCORE)
:QCORE
Sweden Market

Qlucore AB (QCORE) AI Stock Analysis

0 Followers

Top Page

SE:QCORE

Qlucore AB

(QCORE)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
kr0.40
▼(-20.80% Downside)
Action:UpgradedDate:03/03/26
The score is primarily held down by weak financial performance—declining revenue, recently negative gross profit, ongoing losses, and sustained cash burn. Technicals add pressure with the stock trading below key moving averages and negative MACD. Low leverage on the balance sheet provides some stability, but valuation support is limited due to negative earnings and no dividend.
Positive Factors
Recurring software licensing model
A licensing/subscription plus services model creates recurring revenue and customer stickiness common in enterprise life-science software. Over a multi-month horizon this supports predictability of revenue and upsell opportunities (support, training, modules), which can stabilize cash flow as adoption deepens.
Negative Factors
Declining revenue and negative gross profit
Revenue contraction combined with negative gross profit signals that core product economics no longer cover direct costs. This is a structural red flag: unless pricing, product mix or cost base is addressed, gross-margin erosion will continue to undermine long-term profitability and the ability to scale sustainably.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring software licensing model
A licensing/subscription plus services model creates recurring revenue and customer stickiness common in enterprise life-science software. Over a multi-month horizon this supports predictability of revenue and upsell opportunities (support, training, modules), which can stabilize cash flow as adoption deepens.
Read all positive factors

Qlucore AB (QCORE) vs. iShares MSCI Sweden ETF (EWD)

Qlucore AB Business Overview & Revenue Model

Company Description
Qlucore AB (publ) provides bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics AI software for research in life science, biotech, fo...
How the Company Makes Money
Qlucore generates revenue primarily through the sales of its software licenses and subscriptions for Qlucore Omics Explorer. The company offers different pricing tiers based on the features and support included, catering to a range of customers fr...

Qlucore AB Financial Statement Overview

Summary
Financial performance is weak: TTM revenue declined (~11%), gross profit turned negative in the latest periods, and operating/net losses remain large. Cash flow is also a major concern with persistently negative operating and free cash flow and further TTM free-cash-flow deterioration. The balance sheet helps offset some risk with low leverage, but equity has trended down and ROE is consistently negative.
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
BreakdownTTMApr 2024Apr 2023Apr 2022Apr 2022Apr 2021
Income Statement
Total Revenue8.25M10.21M14.37M12.67M14.12M12.94M
Gross Profit-15.75M-9.75M7.40M5.80M5.43M4.42M
EBITDA-31.67M-15.44M-14.98M-15.30M-11.21M-5.45M
Net Income-35.08M-20.54M-15.68M-15.94M-11.66M-6.04M
Balance Sheet
Total Assets51.02M69.95M90.01M109.36M121.90M46.24M
Cash, Cash Equivalents and Short-Term Investments10.90M5.26M28.62M69.73M97.97M27.56M
Total Debt1.55M2.00M3.18M4.46M5.33M4.63M
Total Liabilities11.36M11.49M10.90M14.63M11.34M9.68M
Stockholders Equity39.65M58.47M79.11M94.73M110.56M36.56M
Cash Flow
Free Cash Flow-10.72M-22.38M-39.47M-27.06M-15.76M-5.24M
Operating Cash Flow-10.37M-14.15M-16.95M-8.05M-6.81M-1.08M
Investing Cash Flow-4.43M-8.22M-22.52M-19.02M-8.95M-4.16M
Financing Cash Flow13.79M-1.18M-1.27M-808.00K86.25M28.28M

Qlucore AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.50
Price Trends
50DMA
0.43
Negative
100DMA
0.45
Negative
200DMA
0.51
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
45.42
Neutral
STOCH
68.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:QCORE, the sentiment is Negative. The current price of 0.5 is above the 20-day moving average (MA) of 0.42, above the 50-day MA of 0.43, and below the 200-day MA of 0.51, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.42 is Neutral, neither overbought nor oversold. The STOCH value of 68.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:QCORE.

Qlucore AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
kr432.68M18.383.48%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
58
Neutral
kr150.87M224.82
52
Neutral
kr60.73M24.78
44
Neutral
kr37.38M-5.19
43
Neutral
-1.37-19.87%5.18%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:QCORE
Qlucore AB
0.41
-0.61
-59.90%
SE:DIVIO.B
Divio Technologies AB Class B
0.10
-0.09
-47.09%
SE:FLOWS
Flowscape Technology AB
3.10
-0.05
-1.59%
SE:SFTR
Safeture AB
3.84
-1.26
-24.71%
SE:GENI
Generic Sweden AB
35.20
-19.44
-35.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 03, 2026